PRENW

Prenetics Global Limited operates as a diagnostics and genetic testing company serving consumers and healthcare providers across multiple markets. Headquartered in Hong Kong, the company delivers personalized health solutions through two primary business segments: diagnostic testing and consumer genomics. Its diagnostic division offers COVID-19 testing services and operates clinical laboratories, while its consumer genomics arm provides DNA-based health and wellness insights through direct-to-consumer platforms. The company serves customers across Asia, the United Kingdom, and other international markets through its network of laboratories and digital platforms. Prenetics completed its business combination with Artisan Acquisition Corp in May 2022, becoming publicly traded on NASDAQ. The company operates CircleDNA, a consumer genetics brand offering comprehensive DNA testing for health screening, nutrition, and fitness optimization. Through its ACT Genomics subsidiary, Prenetics provides oncology-focused genomic profiling services to healthcare institutions. The company's diagnostic testing capabilities expanded significantly during the COVID-19 pandemic, establishing large-scale testing operations across Hong Kong and the United Kingdom. The company continues to invest in expanding its laboratory infrastructure and developing its artificial intelligence-driven health insights platform. Prenetics focuses on integrating diagnostic testing with digital health technologies to provide actionable health information, positioning itself within the growing preventive healthcare and precision medicine markets.